Radiopharm Theranostics Ltd ADR (RADX)

$16.19 +10.59 (189.11%)
Market Cap N/A
Revenue (ttm) N/A
Net Income (ttm) N/A
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin N/A
Debt to Equity Ratio N/A
Volume 10,245
Avg Vol N/A
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K N/A
Beta N/A
Analysts Strong Buy
Price Target N/A

Company Profile

Radiopharm Theranostics Limited a clinical-stage radiotherapeutics company, engages in the research and development of radiopharmaceutical products for diagnostic and therapeutic uses in areas with high unmet medical needs. The company develops several products, including RAD101, a pivalate brain metastasis diagnostic; RAD102, a pivalate therapeutic; RAD201a, a Nano-mAb HER-2 breast diagnostic; RAD202, a Nano-mAb HER-2 breast therapeutic; RAD203, a Nano-mAb PDL1 non-small cell lung diagnostic; a...

Industry: Biotechnology
Sector: Healthcare
Phone: 61 3 9824 5254
Fax: 61 3 9822 7735
Address:
62 Lygon Street, Level 3, Carlton, Australia
Manpreet00
Manpreet00 Feb. 24 at 12:36 AM
$RADX ripping in Australia. Up 15%. Expect 20-30% move up tomorrow
0 · Reply
Manpreet00
Manpreet00 Feb. 24 at 12:18 AM
$RADX hopefully we see some movement tomorrow based on the news.
0 · Reply
RadioIsotope25
RadioIsotope25 Feb. 24 at 12:00 AM
Evaluating B7H3 as a target in castration-resistant prostate cancer - YouTube $RADX https://www.youtube.com/watch?v=IINlfEB8XWE
0 · Reply
RadioIsotope25
RadioIsotope25 Feb. 23 at 11:09 PM
MD Anderson made radiopharmaceutical B7-H3 starts trial for $RADX and B7-H3 is a compelling niche that Aktis Oncology has in their pipeline too $AKTS $CATX
0 · Reply
RadioIsotope25
RadioIsotope25 Feb. 23 at 10:39 PM
$RADX First dosing for B7-H3 tons of optionality here for an acquirer it’s a $2 billion dollar a year drug if fda approved for RADX. AKTS has one as well in B7-H3 niche. $AKTS
0 · Reply
RadioIsotope25
RadioIsotope25 Feb. 23 at 10:32 PM
News $RADX
0 · Reply
RadioIsotope25
RadioIsotope25 Feb. 23 at 8:33 PM
$RADX
0 · Reply
RadioIsotope25
RadioIsotope25 Feb. 23 at 4:39 PM
$RADX
0 · Reply
RadioIsotope25
RadioIsotope25 Feb. 23 at 2:26 PM
$RADX If Lantheus acquires RADX for $400 million value they’d only need to issue $340 million in equity since they own 15%.. and if RAD101 does indeed hit $500 million peak sales that would enable them to gain $1.5 billion- 340 million = 1.16 billion in market cap. Plus they’d gain the optionality on all of the pipeline RADX has and for example RAD202 is a potential $2 billion dollar a year drug so that could if it got approved add $6 billion in market cap alone.
0 · Reply
athebeast
athebeast Feb. 23 at 2:09 PM
$IBRX @OmarKingW Don't trust @intrader , dude had the same energy and attitude towards $RADX and his trade lost 50% and he was acting just like this about it talking about a cure for cancer and a bunch of nonsense. Be cautious, i short 80% of the stocks he trades successfully. ⚠️💸💰
0 · Reply
Latest News on RADX
Radiopharm Theranostics Reports Half-Year Financial Results and Business Updates

Wed, 28 Jan 2026 07:00:00 -0500 - 26 days ago

Radiopharm Theranostics Reports Half-Year Financial Results and Business Updates

RAD Increases Ownership in Radiopharm Ventures to 87.5%

Mon, 12 Jan 2026 07:00:00 -0500 - 6 weeks ago

RAD Increases Ownership in Radiopharm Ventures to 87.5%

Why Is Radiopharm Theranostics Stock Rallying Over 140%?

Mon, 15 Dec 2025 11:59:59 -0500 - 2 months ago

Why Is Radiopharm Theranostics Stock Rallying Over 140%?

Radiopharm Theranostics Achieves Primary Endpoint in 92% of Patients at Interim Analysis of RAD 101 Phase 2b Imaging Trial in Brain Metastases

Mon, 15 Dec 2025 07:00:00 -0500 - 2 months ago

Radiopharm Theranostics Achieves Primary Endpoint in 92% of Patients at Interim Analysis of RAD 101 Phase 2b Imaging Trial in Brain Metastases

Radiopharm Theranostics (RADX): Analyst Maintains 'Buy' as Price Target Adjusts | RADX Stock News

2025-11-26T18:34:17.000Z - 3 months ago

Radiopharm Theranostics (RADX): Analyst Maintains 'Buy' as Price Target Adjusts | RADX Stock News

Lantheus (LNTH) Commits to Significant Investment in Radiopharm Theranostics

2025-10-20T13:30:38.000Z - 4 months ago

Lantheus (LNTH) Commits to Significant Investment in Radiopharm Theranostics

Radiopharm Theranostics completes A$35 million Placement and launches a A$5 million Share Purchase Plan

Mon, 20 Oct 2025 07:30:00 -0400 - 4 months ago

Radiopharm Theranostics completes A$35 million Placement and launches a A$5 million Share Purchase Plan

Regal-backed biotech Radiopharm Theranostics launches $35m placement

2025-10-15T23:01:20.000Z - 4 months ago

Regal-backed biotech Radiopharm Theranostics launches $35m placement

Radiopharm Theranostics Limited - Special Call

2025-09-02T05:15:35.000Z - 6 months ago

Radiopharm Theranostics Limited - Special Call

Radiopharm Theranostics reports Fiscal Year 2025 Financial Results and Business Update

Tue, 29 Jul 2025 07:30:00 -0400 - 7 months ago

Radiopharm Theranostics reports Fiscal Year 2025 Financial Results and Business Update

Dr Oliver Sartor Appointed to Radiopharm Scientific Advisory Board

Tue, 22 Jul 2025 08:00:00 -0400 - 7 months ago

Dr Oliver Sartor Appointed to Radiopharm Scientific Advisory Board

Radiopharm Theranostics Reports Preclinical Lu177-B7H3-mAb Data Demonstrating Favourable Biodistribution and High Tumour Uptake

Mon, 02 Jun 2025 08:00:00 -0400 - 9 months ago

Radiopharm Theranostics Reports Preclinical Lu177-B7H3-mAb Data Demonstrating Favourable Biodistribution and High Tumour Uptake

ITM and Radiopharm Sign Supply Agreement for n.c.a. Lutetium-177

Mon, 19 May 2025 08:00:00 -0400 - 10 months ago

ITM and Radiopharm Sign Supply Agreement for n.c.a. Lutetium-177

Radiopharm Theranostics: Radiotherapeutic Biotech With PD-L1 And HER2 Targeting

2025-03-27T19:13:09.000Z - 11 months ago

Radiopharm Theranostics: Radiotherapeutic Biotech With PD-L1 And HER2 Targeting

This S&P Global Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday

2025-03-12T16:57:48.000Z - 1 year ago

This S&P Global Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday

Radiopharm Announces Strategic Co-Development Partnership with Lantheus for Australia

Mon, 30 Dec 2024 08:00:00 -0500 - 1 year ago

Radiopharm Announces Strategic Co-Development Partnership with Lantheus for Australia

RAD 202 Receives Approval to Start Phase 1 Therapeutic Trial

Fri, 20 Dec 2024 08:00:00 -0500 - 1 year ago

RAD 202 Receives Approval to Start Phase 1 Therapeutic Trial

Deutsche Bank Appointed as Depositary Bank for the Sponsored American Depositary Receipt Program of Radiopharm Theranostics Limited

Thu, 19 Sep 2024 12:00:00 -0400 - 1 year ago

Deutsche Bank Appointed as Depositary Bank for the Sponsored American Depositary Receipt Program of Radiopharm Theranostics Limited

Manpreet00
Manpreet00 Feb. 24 at 12:36 AM
$RADX ripping in Australia. Up 15%. Expect 20-30% move up tomorrow
0 · Reply
Manpreet00
Manpreet00 Feb. 24 at 12:18 AM
$RADX hopefully we see some movement tomorrow based on the news.
0 · Reply
RadioIsotope25
RadioIsotope25 Feb. 24 at 12:00 AM
Evaluating B7H3 as a target in castration-resistant prostate cancer - YouTube $RADX https://www.youtube.com/watch?v=IINlfEB8XWE
0 · Reply
RadioIsotope25
RadioIsotope25 Feb. 23 at 11:09 PM
MD Anderson made radiopharmaceutical B7-H3 starts trial for $RADX and B7-H3 is a compelling niche that Aktis Oncology has in their pipeline too $AKTS $CATX
0 · Reply
RadioIsotope25
RadioIsotope25 Feb. 23 at 10:39 PM
$RADX First dosing for B7-H3 tons of optionality here for an acquirer it’s a $2 billion dollar a year drug if fda approved for RADX. AKTS has one as well in B7-H3 niche. $AKTS
0 · Reply
RadioIsotope25
RadioIsotope25 Feb. 23 at 10:32 PM
News $RADX
0 · Reply
RadioIsotope25
RadioIsotope25 Feb. 23 at 8:33 PM
$RADX
0 · Reply
RadioIsotope25
RadioIsotope25 Feb. 23 at 4:39 PM
$RADX
0 · Reply
RadioIsotope25
RadioIsotope25 Feb. 23 at 2:26 PM
$RADX If Lantheus acquires RADX for $400 million value they’d only need to issue $340 million in equity since they own 15%.. and if RAD101 does indeed hit $500 million peak sales that would enable them to gain $1.5 billion- 340 million = 1.16 billion in market cap. Plus they’d gain the optionality on all of the pipeline RADX has and for example RAD202 is a potential $2 billion dollar a year drug so that could if it got approved add $6 billion in market cap alone.
0 · Reply
athebeast
athebeast Feb. 23 at 2:09 PM
$IBRX @OmarKingW Don't trust @intrader , dude had the same energy and attitude towards $RADX and his trade lost 50% and he was acting just like this about it talking about a cure for cancer and a bunch of nonsense. Be cautious, i short 80% of the stocks he trades successfully. ⚠️💸💰
0 · Reply
alsworthg
alsworthg Feb. 22 at 6:26 PM
$UAMY $IBRX $RADX LFG. Snow day tomorrow so I can stay home and watch us fly!!!!
2 · Reply
RadioIsotope25
RadioIsotope25 Feb. 21 at 10:40 PM
Radiopharm’s imaging molecule hits mark in observational trial for $500 million dollar first of its kind imaging agent- potentially 3rd largest imaging agent in USA- Clinical Trials Arena $RADX $CATX $AKTS $LNTH https://www.clinicaltrialsarena.com/news/radiopharms-imaging-molecule-hits-mark-in-observational-trial/
0 · Reply
RadioIsotope25
RadioIsotope25 Feb. 21 at 1:32 AM
Radiopharmaceutical therapy use has increased 2,000% among Medicare population This is good news for this industry $RADX $CATX https://radiologybusiness.com/topics/medical-imaging/nuclear-medicine/radiopharmaceutical-therapy-use-has-increased-2000-among-medicare-population
0 · Reply
RadioIsotope25
RadioIsotope25 Feb. 20 at 5:08 PM
Up 85% on Radiopharm imaging data past 90 days $RADX $CATX
1 · Reply
RadioIsotope25
RadioIsotope25 Feb. 20 at 4:39 PM
$RADX
0 · Reply
fillzane
fillzane Feb. 20 at 3:55 PM
$RADX Radiopharm Theranostics develops radiopharmaceutical cancer treatments. Clinical milestones are key catalysts. Development risk is high.
1 · Reply
RadioIsotope25
RadioIsotope25 Feb. 20 at 3:29 PM
Trump's sweeping global tariffs struck down by US Supreme Court ruling - follow live - BBC News $RADX https://www.bbc.com/news/live/c0l9r67drg7t
0 · Reply
RadioIsotope25
RadioIsotope25 Feb. 20 at 2:53 PM
Recipe for hard bounce on any news. Hard to borrow and only 35,000 available $RADX
0 · Reply
RadioIsotope25
RadioIsotope25 Feb. 20 at 2:43 PM
$RADX Aktis = dead money until data up to 12 mos TLX= rebounding now up 14% last night RADX= up in Australia last night 3% and major data catalysts all 2026. Rad101 affirmation data major de-risk and pipe of 3-4 others with data. CaTX= probably worth more if more data keeps falling in their favor $CATX $PSTV $AKTS
0 · Reply
alsworthg
alsworthg Feb. 19 at 10:36 PM
$RADX I know we will get some love here someday
1 · Reply
outlawinvestor1
outlawinvestor1 Feb. 19 at 10:27 PM
$CATX great play so far! much more room to run! $RADX is another radiopharm player with lots of potential.
0 · Reply
RadioIsotope25
RadioIsotope25 Feb. 19 at 5:59 PM
$RADX Looks like if we get through 90 and 200 day moving average this goes to $7+ 90 day $5.12 120 day $5.17
0 · Reply